APVO Latest Press Releases

-- November 12, 2026 --

Aptevo Therapeutics Announces Closing of Existing Warrants Exercise for $3.0 Million Gross Proceeds ACCESS Newswire 4:15 PM

-- November 11, 2026 --

Aptevo Therapeutics Announces Exercise of Existing Warrants for $3.0 Million Gross Proceeds ACCESS Newswire 9:00 AM

-- November 9, 2026 --

Aptevo Presents Preclinical Data at SITC 2026 Showing Potential to Overcome Immune Suppression in Solid Tumors ACCESS Newswire 8:30 AM

-- November 5, 2026 --

Aptevo Achieves Key Clinical Development Objective, Significantly Reducing Infusion-Related Reactions with Mipletamig in Frontline AML ACCESS Newswire 8:30 AM

-- October 26, 2026 --

Aptevo Reports Mipletamig Combination Therapy Enabled 21% of Frontline AML Patients to Advance to Potentially Curative Stem Cell Transplant ACCESS Newswire 8:05 AM

-- October 14, 2026 --

Aptevo to Showcase Multispecific Platform at SITC 2026 Annual Meeting ACCESS Newswire 8:46 AM

-- September 24, 2026 --

Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development ACCESS Newswire 8:05 AM

-- September 3, 2026 --

Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML ACCESS Newswire 8:05 AM

-- August 14, 2026 --

Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results ACCESS Newswire 8:05 AM

-- August 13, 2026 --

Aptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds ACCESS Newswire 4:05 PM

-- August 12, 2026 --

Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds ACCESS Newswire 9:33 AM

-- July 27, 2026 --

Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone ACCESS Newswire 8:05 AM

-- June 30, 2026 --

Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors ACCESS Newswire 8:05 AM

Market Data Delayed 15 Minutes